Methods of assessing the risk for the development of sporadic prostate cancer
US7427482B2 · kind B2 · utility
2Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 2005 |
| Grant date | Sep 23, 2008 |
| Priority date | — |
| Expiry date | Jun 9, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the genomic sequence of the purH gene. The invention also concerns biallelic markers of a purH gene and the association established between these markers and cancer, particularly prostate cancer. The invention provides means to determine the predisposition of individuals to cancer as well as means for the diagnosis of cancer and for the prognosis/detection of an eventual treatment response to agents acting on cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.